Lisa Carberg

1 week ago | wtnh.com | Lisa Carberg

HARTFORD, Conn. (WTNH) — When emergencies like heart attacks happen, medical professionals aren’t always nearby to help save their lives. Sometimes, it can happen in a restaurant, so the Max Restaurant Group and Hartford HealthCare are teaming up to offer lifesaving training, called Choking, Stop the Bleed and CPR class.

1 week ago | yahoo.com | Lisa Carberg

HARTFORD, Conn. (WTNH) — When emergencies like heart attacks happen, medical professionals aren’t always nearby to help save their lives. Sometimes, it can happen in a restaurant, so the Max Restaurant Group and Hartford HealthCare are teaming up to offer lifesaving training, called Choking, Stop the Bleed and CPR class.

1 week ago | wtnh.com | Lisa Carberg

GALES FERRY, Conn. (WTNH) — Within the past few years, the FDA approved two groundbreaking drugs that in trials were shown to reduce brain plaque by 27% in some Alzheimer’s patients. Bruce Meyer of Gales Ferry started experiencing mild cognitive decline in 2011. He spent 11 years in eight different Alzheimer’s drug trials. Mostly recently, they have been through the Dorothy Adler Geriatric Assesment Center at Yale Medicine.

2 weeks ago | yahoo.com | Lisa Carberg

GALES FERRY, Conn. (WTNH) — Within the past few years, the FDA approved two groundbreaking drugs that in trials were shown to reduce brain plaque by 27% in some Alzheimer’s patients. Yale researchers use lupus antibody to possibly treat glioblastoma Bruce Meyer of Gales Ferry started experiencing mild cognitive decline in 2011. He spent 11 years in eight different Alzheimer’s drug trials. Mostly recently, they have been through the Dorothy Adler Geriatric Assesment Center at Yale Medicine.

4 weeks ago | wtnh.com | Lisa Carberg

NEW HAVEN, Conn. (WTNH) — Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other aggressive cancers that are extremely difficult to treat. Dr. James Hansen, a Yale Cancer Center researcher, and his team discovered that using an antibody related to lupus they can breach the tumor and trigger an immune response to fight it.